Most common clinical presentations of cutaneous mastocytosis

Acta Clinica Croatica, Supplement

Volumn 48, Issue 1, 2009, Pages 59-64

  Bulat, Vedrana ^a   Mihić, Liborija Lugović ^a   Šitum, Mirna ^a   Buljan, Marija ^a   Blajić, Iva ^a   Pušić, Jana ^b  

^a SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^b Zagreb Centar Health Center   (Croatia)

Author keywords

Mast cells pathology; Mastocytosis, cutaneous diagnosis; Mastocytosis, cutaneous pathology; Mastocytosis, cutaneous therapy; Skin pathology

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA2B INTERFERON; ANTIHISTAMINIC AGENT; CHLORAMBUCIL; CROMOGLYCATE DISODIUM; MERCAPTOPURINE; METHOTREXATE; PSORALEN; VINBLASTINE; VINCRISTINE; ADRENALIN; IMATINIB;

ADOLESCENCE; ARTICLE; BLISTER; CELL HYPERPLASIA; CLINICAL FEATURE; DARIER DISEASE; DERMIS; DERMOGRAPHISM; DISEASE COURSE; FACE; FATALITY; HUMAN; LIFE; MAST CELL; MAST CELL LEUKEMIA; MUCOSA; PAPULE; PEDIATRICS; PROGNOSIS; SKIN DISEASE; SKIN PIGMENTATION; SKIN PRURITUS; SOLITARY MASTOCYTOMA; SPASTICITY; TRUNK; URTICARIA PIGMENTOSA; ERYTHEMA; HYPERPLASIA; HYPOTENSION; MASTOCYTOSIS; PRURITUS; RASH; REVIEW; STOMACH ACID; SYSTEMIC MASTOCYTOSIS; TELANGIECTASIA; ULTRAVIOLET RADIATION; VIRUS CULTURE;

HUMANS; MASTOCYTOSIS, CUTANEOUS; PROGNOSIS;

EID: 67651015586     PISSN: 03539474     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. nd ed. Philadelphia: Elsevier; 2005;301-315
2. CHURCH MK, LEI-SCHAFFER F. The human mast cell. J Allergy Clin Immunol 1997;99:155-160
3. nd ed. St. Louis: Mosby, 1998:146-167
4. METCALFE DD. Mast cells and mastocytosis. Blood 2008;112:946-956
5. KETTELHUT BV, METCALFE DD. Pediatric mastocytosis. J Invest Dermatol 1991;96:15-18
6. AKOGLU G, ERKIN G, CAKIR B, BOZTEPE G, SAHIN S, KARADUMAN A, ATAKAN N, AKAN T, KOLEMEN F. Cutaneous mastocytosis: demographic aspects and clinical features of 55 patients. JEADV 2006;20:969-973 (Pubitemid 44241386)
7. ANGUS J, LEACH IH, GRANT J, RAVENSCROFT C. Systemic mastocytosis with diffuse cutaneous involvement and haematological disease presenting in utero treated unsuccessfully with vincristine. Clin Exp Dermatol 2008;33:36-39 (Pubitemid 350308525)
8. nd ed. Berlin: Springer-Verlag, 2000:1649-1655
9. WOLFF K, KOMAR M, PETZELBAUER P. Clinical and histopathological aspects of cutaneous mastocytosis. Leuk Res 2001;25:519-528 (Pubitemid 32506758)
10. nd ed. Allergy. London: Mosby, 2001:303-310
11. st ed. Philadelphia: Churchill Livingstone, 2000:146-156
12. HOLLMANN TJ, BRENN T, HORNICK JL. CD25 expression on cutaneous mast cells from adult patients presenting with urticaria pigmentosa is predictive of systemic mastocytosis. Am J Surg Pathol 2008;32:139-145
13. HORNY HP, SOTLAR K, VALENT P. Mastocytosis: state of the art. Pathobiology 2007;74:121-132
14. nd ed. Principles and practice of dermatology. New York: Churchill Livingstone, 1996:333-339
15. BROCKOW K, JOFER C, BEHRENDT H, RING J. Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients. Allergy 2008;63:226-32.
16. BUTTERFIELD JH. Response of severe systemic mastocytosis to interferon alpha. Br J Dermatol 1998;138:489-495 (Pubitemid 28145521)
17. MURPHY M, WALSH D, DRUMM B, WATSON R. Bullous mastocytosis: a fatal outcome. Pediatr Dermatol 1999;16:452-455